ImmunoGenAlmost four years after backing out of an antibody-drug conjugate (ADC) alliance with ImmunoGen, Eli Lilly has come back to the table with a new, wide-ranging deal worth up to $1.7 billion.
The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...
In power converters and power distribution networks (PDNs), mixing capacitors like high-inductance and high-capacity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results